Results 41 to 50 of about 132,194 (344)

Adherence to Hospital Antibiotic Policy for Treatment of Escherichia coli ESBL in Urine [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Introduction: Escherichia coli are the most common uropathogen worldwide accounting for 80% of the Urinary Tract Infections (UTIs). Nosocomial infections caused by Multi-drug resistant Gram negative bacteria expressing Extended Spectrum β Lactamase ...
R. Someshwaran   +3 more
doaj   +1 more source

Risk Factors and Treatment Outcome Analysis Associated with Second-Line Drug-Resistant Tuberculosis

open access: yesJournal of Respiration, 2021
The present study aimed at analyzing the treatment outcomes and risk factors associated with fluoroquinolone drug resistance having mutations in the gyrA and gyrB genes.
Muralidhar Aaina   +5 more
doaj   +1 more source

Timing of DNA damage responses impacts persistence to fluoroquinolones

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2018
Significance Bacterial persisters are able to survive high concentrations of antibiotics that kill their genetically identical kin. Their tolerances are thought to arise from decreased activity of cellular processes, which limits damage from antibiotics.
Wendy W. K. Mok, M. P. Brynildsen
semanticscholar   +1 more source

Revisiting Oral Fluoroquinolone and Multivalent Cation Drug-Drug Interactions: Are They Still Relevant?

open access: yesAntibiotics, 2019
Fluoroquinolones are a widely-prescribed, broad-spectrum class of antibiotics with several oral formulations notable for their high bioavailability. For certain infections, fluoroquinolones are the first line or only treatment choice.
Stuart K. Pitman   +5 more
doaj   +1 more source

The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019

open access: yesDrugs, 2019
The inability to use powerful antituberculosis drugs in an increasing number of patients seems to be the biggest threat towards global tuberculosis (TB) elimination.
A. Pranger   +5 more
semanticscholar   +1 more source

Community Acquired Pneumonia [PDF]

open access: yes, 2017
Community acquired pneumonia is discussed, including the pathophysiology, treatment, patient education, and nursing practice ...
Foering, Allison
core   +2 more sources

Periodontal microbiology and microbial etiology of periodontal diseases: Historical concepts and contemporary perspectives

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract This narrative review summarizes the collective knowledge on periodontal microbiology, through a historical timeline that highlights the European contribution in the global field. The etiological concepts on periodontal disease culminate to the ecological plaque hypothesis and its dysbiosis‐centered interpretation.
Georgios N. Belibasakis   +5 more
wiley   +1 more source

Lomefloxacin—Occurrence in the German River Erft, Its Photo-Induced Elimination, and Assessment of Ecotoxicity

open access: yesClean Technologies, 2020
Pharmaceuticals in waters represent a worldwide problem of today. Advanced oxidation processes (AOPs) are being researched for elimination of the ecological hazard.
Melanie Voigt   +6 more
doaj   +1 more source

The Use of Systemic and Topical Fluoroquinolones

open access: yesPediatrics, 2016
Appropriate prescribing practices for fluoroquinolones, as well as all antimicrobial agents, are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in ...
M. Jackson, G. Schutze
semanticscholar   +1 more source

Impact of Fluoroquinolones on Tendon Health: A Comprehensive Overview for the General Population and Athletes

open access: yesQuality in Sport
Introduction: Fluoroquinolones are a class of broad-spectrum antibiotics widely used to treat various bacterial infections. Despite their effectiveness, increasing evidence links fluoroquinolones to tendinopathy and tendon rupture, with cases occurring ...
Emilia Kucharczyk   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy